ALC - Alcon swings to small net income in Q3 2021 driven by increase in surgical sales

Alcon (NYSE:ALC) swung to net income of $2M in Q3 2021 from a loss of $147M in prior-year due in part to a boost in sales in its surgical business. Sales in that division were ~1.2B, a ~17% increase compared to Q3 2020. Vision care sales rose ~12% to $923M. R&D expenses increased 47% to 318M, while SG&A expenses increased ~14% to $779M. Alcon ended the quarter with $1.6B in cash. Read about Alcon's recent acquisition of Ivantis.

For further details see:

Alcon swings to small net income in Q3 2021 driven by increase in surgical sales